Skip to main content
. Author manuscript; available in PMC: 2010 Jun 18.
Published in final edited form as: J Infect Dis. 2010 Jan 15;201(2):293–296. doi: 10.1086/649569

Figure 1.

Figure 1

Latent reservoir in human immunodeficiency virus type 1 (HIV-1)–infected patients receiving intensive enfuvirtide-containing anti-retroviral therapy (ART) who had sustained virologic suppression and remained on enfuvirtide for at least 48 weeks (solid lines). The 95% confidence interval for the half-life of the latent reservoir is 11 months to infinity. Dashed lines represent the mean decay slope and 95% confidence intervals from measurements of the latent reservoir in 62 patients who were on ART regimens that did not contain enfuvirtide (historical controls) [4]. IUPM, infectious units per million cells.